Comanche Biopharma has filed a notice of an exempt offering of securities to raise $36,100,007.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Comanche Biopharma is raising $36,100,007.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Johnson played a key role…